Alliance for Genomic Discovery Archives
What could be next? Preview DNA’s Season 4 exploring the future
Sep. 25, 2023—Preview the trailer for Season 4 of the Vanderbilt Health DNA podcast series. Explore issues facing businesses across industries, and how VUMC is experimenting with and designing solutions for problems — old and new — by supporting smart people with visionary ideas.
The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck
Jul. 18, 2023—Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.
Alliance for Genomic Discovery FAQs
Jul. 18, 2023—Here are frequently asked questions about Vanderbilt University Medical Center's Alliance for Genomic Discovery.
Nashville Biosciences and Illumina announce sequencing agreement with Amgen
Jan. 9, 2023—Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.
